Skip to main content
Fig. 5 | Translational Medicine Communications

Fig. 5

From: Safety and efficacy of autologous non-hematopoietic enriched stem cell nebulization in COVID-19 patients: a randomized clinical trial, Abu Dhabi 2020

Fig. 5

Clinical impact on the assessed outcomes. Legend: NLR: Neutrophil to Lymphocyte Ratio; CRP: C-Reactive Protein; EI0: Exposure Incidence in controls; EI: Exposure Incidence in peripheral blood non-hematopoietic enriched stem cell cocktail treated-patients; RR: relative risk; 95% CI: confidence interval; RRR: relative risk reduction; NNT: number needed to treat to produce the effect; a: Z-test. *: significant; **: highly significant

Back to article page